生命科学讲座(肿疡生物学).pdf

1. Honma, Y., Akimoto, M. Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents. Cancer Science, 98:1643-1651, 2007. 2. Horie, A., Akimoto, M., Tsumura, H., Makishima, M., Taketani, T., Yamaguchi, S., Honma, Y. Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile derivative, and cooperative effects with another differentiation inducer, cotylenin A. Leuk Res 32:1112-1123, 2008. 3. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J-I. ROS-generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis. Science 320: 661-664, 2008. 4. Kasukabe T, Okabe-Kado J, Honma Y. Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G . Cancer Science 99: 1693-1698, 2008. 2 5. Ishikawa K, Hashizume O, Koshikawa N, Fukuda S, Nakada K, Takenaga K, Hayashi J. Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis. FEBS Lett. 582: 3525-3530, 2008. 6. Ishikawa K, Koshikawa N, Takenaga K, Nakada K, Hayashi J. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion. 8: 339-344, 2008. 7. . , 26 (13): 2067-2073, 2008. 1 II 1. Yoshio Honma, Miho Akimoto, Takeshi Sassa, Nobuo Kato: Fusicoccin derivatives as therapeutic agents based on induction of differentiation. AACR/NCI/EORTC International Conference. 10.22-28, 2007. Moscone West Convention Center,